Serial measurements of serum PDGF-AA, PDGF-BB, FGF2, and VEGF in multiresistant ovarian cancer patients treated with bevacizumab

INTRODUCTION: Anti-VEGF treatment has proven effective in recurrent ovarian cancer. However, the identification of the patients most likely to respond is still pending. It is well known that the angiogenesis is regulated by several other pro-angiogenic proteins, e.g. the platelet - derived growth fa...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Madsen, Christine Vestergaard, Steffensen, Karina Dahl, Olsen, Dorte Aalund, Waldstrøm, Marianne, Smerdel, Maja, Adimi, Parvin, Brandslund, Ivan, Jakobsen, Anders
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2012
Teme:
Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3511256/
https://ncbi.nlm.nih.gov/pubmed/22989094
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1757-2215-5-23
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki